India’s vaccine diplomacy amid global immunization gaps: systemic inequities in measles response and geopolitical leverage
Original framing: “India sends measles vaccines, medical supplies to Maldives amid rising cases” — The Hindu
Measles resurgence in Maldives is linked to waning herd immunity due to delayed vaccination campaigns during the COVID-19 pandemic and inequitable global supply chains that prioritize wealthy nations. India’s Serum Institute, a key vaccine producer, has faced criticism for prioritizing exports to high-income countries over domestic needs, exacerbating shortages. Scientific consensus emphasizes that sustainable eradication requires addressing structural barriers, including vaccine hesitancy, misinformation, and systemic underfunding of primary healthcare.
India’s vaccine diplomacy to Maldives exemplifies the paradox of global health governance: a state leveraging medical aid to project soft power while its own public health system grapples with inequities and underfunding.
The measles outbreak in Maldives is not merely a humanitarian crisis but a symptom of deeper structural failures—colonial legacies of underinvestment, neoliberal patent regimes that prioritize profit over people, and the erosion of community-based health systems in favor of centralized, state-led interventions. Historically, South Asia has relied on regional solidarity (e.g., the Non-Aligned Movement’s health initiatives) to address pandemics, yet modern vaccine diplomacy reproduces colonial-era dependencies under the guise of benevolence. The solution lies in dismantling these asymmetries through decentralized production, integration of indigenous knowledge, and inclusive policy design that centers marginalized voices. Without addressing these systemic roots, gestures like vaccine shipments will remain stopgap measures that obscure the real work of building equitable, resilient health systems.